The ADDF co-developed and organized the 6th International Conference on Pharmacoeconomics on Alzheimer’s Disease (IPECAD) meeting with the Karolinska Institutet, Stockholm. IPECAD is the only conference that exclusively addresses issues related to the economic evaluation of drug treatments for Alzheimer’s disease. It brings together leading experts and opinion leaders from academia, regulatory bodies and the pharmaceutical industry. Approximately 75 health economists and scientists from around the world attended this meeting.
For more information, please visit the IPECAD website.